Alexandria Real Estate Equities has seen its share price fall sharply over recent years, which puts the focus squarely on whether the current US$44.30 level reflects the cash it can generate from its life science properties. With investors watching both redevelopment projects and long term leases, the open question is how those cash flows line up against where the stock trades today.
The issue now is whether the current share price is adequately supported by the cash flows implied in the Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing Alexandria Real Estate Equities on its cash flows and want more ideas built around resilient profiles, a focused stock screen such as 29 resilient stocks with low risk scores can help start that research.
The Discounted Cash Flow (DCF) model here is built around Alexandria Real Estate Equities' adjusted funds from operations. On this view, the trust is generating trailing twelve month free cash flow of about $1.53b, with analysts and modelled estimates pointing to free cash flow in the mid hundreds of millions of $ over the coming decade. This implies a growing but relatively measured profile rather than a boom and bust pattern.
The DCF outcome suggests an intrinsic value that sits meaningfully above the current $44.30 share price, so the market is treating those projected cash flows cautiously. Redevelopment of Tanforan Mall into a life science campus in San Bruno helps explain why expectations still build around ongoing cash generation, because long leases on lab and office space can support the kind of steady adjusted funds from operations that underpin this valuation gap. Find out what Alexandria Real Estate Equities could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives pick up where the valuation question for Alexandria Real Estate Equities' cash flows leaves off. They spell out which assumptions on growth, margins and earnings would need to hold for the shares to be worth meaningfully more or less than where they trade today on the Community page. Each scenario ties a fair value to a particular mix of potential catalysts and key risks so you can track which storyline about the trust gradually matches reality.
Bulls and bears on Alexandria Real Estate Equities are both looking at the same life science portfolio and cash flows, then reaching very different conclusions.
Bull case: 50% undervalued
According to Ivoed, a Simply Wall St Community investor who wrote the bullish Narrative, the gap starts with how Alexandria Real Estate Equities is priced against its assets.
"As a starting point, we take NAV per share of approximately $98, representing intrinsic value based on book equity divided by shares outstanding…"
Discover why this Narrative puts Alexandria Real Estate Equities at 50% undervalued.
Bear case: 20% overvalued
The bearish analyst Narrative on Simply Wall St argues that today’s price already bakes in a cleaner, more profitable version of Alexandria Real Estate Equities than recent results show.
"The current numbers on occupancy, NOI pressure, impairments, and planned capital recycling together imply a share price that already reflects a cleaner, more profitable portfolio…"
Explore why this Narrative puts Alexandria Real Estate Equities at 20% overvalued.
Cash flow and narratives only tell part of the story. Our broader checks on Alexandria Real Estate Equities have flagged several cautions that deserve a closer look before you commit fresh capital. Take a closer look at 3 warning signs (1 major) before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com